Nurofen Patch (Ibuprofen)

Ibuprofen in the patch inhibits the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, reducing the synthesis of prostaglandins that mediate inflammation, pain and fever. By acting locally at the site of application, the drug diminishes inflammatory signaling and alleviates discomfort in the underlying tissues.

The appropriate dosing regimen for Nurofen Patch is determined by a qualified healthcare professional based on the individual’s condition, age, and treatment duration. Patients should follow the prescriber’s instructions and the product label, and should not alter the number of patches or the frequency of application without medical advice.

Safety data for topical ibuprofen during pregnancy and lactation are limited. Healthcare providers generally advise caution and may recommend alternative therapies, especially in the first trimester. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and benefits with their physician before using the patch.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details and any necessary import documentation.

Both formulations contain the same active ingredient, ibuprofen, but the patch delivers the drug directly through the skin, which can reduce systemic exposure and gastrointestinal side effects associated with oral intake. The patch is useful for localized pain where a targeted effect is desired, whereas oral ibuprofen provides systemic relief for broader pain conditions.

Store the patch at room temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and excessive heat. Do not refrigerate or freeze the patches, as temperature extremes may affect adhesive properties and drug stability.

Clean and dry the intended skin area before application. Remove the protective liner and press the adhesive side of the patch firmly onto the skin for at least 30 seconds. Avoid overlapping patches and do not apply to broken, irritated or infected skin. Follow the duration recommended by the prescriber, typically a few hours per application.

Serious risks include severe allergic reactions such as angio‑edema, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and systemic NSAID toxicity that can lead to gastrointestinal bleeding, ulceration or renal impairment. Patients should seek immediate medical attention if they experience swelling of the face or throat, widespread rash, or signs of internal bleeding.

Individuals with known hypersensitivity to ibuprofen, other NSAIDs, or any component of the patch should avoid its use. It is also contraindicated in patients with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or those taking anticoagulants without medical supervision. Pregnant women, especially in the first trimester, should consult a physician before use.